PTAB Urged To Nix Reviews Sought By Bass-Affiliated Group

By Kevin Penton (December 9, 2015, 4:46 PM EST) -- The University of Pennsylvania's trustees fought back on Tuesday against attempts by a group with close ties to hedge fund manager Kyle Bass to invalidate two patents related to the cholesterol drug Juxtapid, telling the Patent Trial and Appeal Board that the examples cited do not make the patents obvious....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!